Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK-mediated DR5 regulation in colorectal cancer

International Journal of Oncology
Se-Lim KimSang-Wook Kim

Abstract

TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis through death receptors (DRs)4 and/or 5 expressed on the cell surface. Multiple clinical trials are underway to evaluate the antitumor activity of recombinant human TRAIL and agonistic antibodies to DR4 or DR5. However, their therapeutic potential is limited by the high frequency of cancer resistance. In this study, we provide evidence demonstrating the role of lipocalin 2 (LCN2) in the TRAIL-mediated apoptosis of human colorectal cancer (CRC). By analyzing the mRNA expression data of 71 CRC tissues from patients, we found that DR5 was preferentially expressed in CRC tissues with a low LCN2 expression level compared to tissues with a high LCN2 expression level. Moreover, we analyzed the association between DR5 and LCN2 expression and this analysis revealed that DR5 expression in CRC tended to be inversely associated with LCN2 expression. By contrast, no association was found between the DR4 and LCN2 expression levels. The expression patterns of LCN2 in human CRC cell lines also exhibited an inverse association with DR5 expression. The knockdown of LCN2 by siRNA in the TRAIL‑resistant CRC cells expressing high levels of LCN2 led to a significant increase in TRAIL-in...Continue Reading

References

Jul 10, 1997·Nature·M IrmlerJ Tschopp
Nov 5, 1997·Nature Genetics·G S WuW S el-Deiry
Jul 31, 1999·The Journal of Biological Chemistry·C ScaffidiM E Peter
Nov 4, 2000·Biochimica Et Biophysica Acta·A Skerra
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Nov 28, 2002·Molecular Cell·Jun YangJonathan Barasch
Mar 26, 2003·Seminars in Cancer Biology·Nesrin Ozören, Wafik S El-Deiry
Aug 24, 2004·The Journal of Biological Chemistry·Hirohito Yamaguchi, Hong-Gang Wang
Dec 27, 2005·Cell·Laxminarayana R DevireddyMichael R Green
Dec 29, 2005·International Journal of Cancer. Journal International Du Cancer·Ho-Jeong LeeJang-Seong Kim
May 29, 2007·Oncogene·K TakedaM J Smyth
Jul 22, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Avi AshkenaziS Gail Eckhardt
Apr 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric Van CutsemFortunato Ciardiello
Jan 12, 2012·Molecular Cancer Therapeutics·Christian T Hellwig, Markus Rehm
Apr 26, 2012·Cancer Letters·Martha W den HollanderElisabeth G E de Vries
Mar 4, 2014·World Journal of Gastroenterology : WJG·Bruno Christian KoehlerHenning Schulze-Bergkamen
Apr 20, 2014·Oncotarget·Saverio CandidoMassimo Libra
May 29, 2014·International Journal of Cancer. Journal International Du Cancer·Marzia PennatiNadia Zaffaroni
Jun 12, 2014·Cancer Chemotherapy and Pharmacology·Lei ChengXiao-Ping Qian
Jun 17, 2014·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Minh Truong DoHye Gwang Jeong
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Oct 23, 2014·International Journal of Critical Illness and Injury Science·Scienthia SanjeevaniOm Prakash Kalra
Jan 7, 2015·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Jan 26, 2018·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Cai YanLi Kongdan

❮ Previous
Next ❯

Citations

Mar 7, 2021·International Journal of Molecular Sciences·Silvia PeregoGiovanni Lombardi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.